Position in EXEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,269,170
+$1,405,986 QoQ
Shares Held
60,084
+38.3% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#217
of 754 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Horizon Investments, LLC holds $37,596,715 across 22 Biotechnology names. EXEL ranks #4 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
22,215 | $11,034,856 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,799 | $6,733,608 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
18,295 | $4,408,546 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
60,084 | $3,269,170 | |
| 5 | INCY |
Incyte Corp
|
22,774 | $2,581,660 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
40,323 | $2,307,282 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
46,510 | $1,645,988 | |
| 8 | INVA |
Innoviva, Inc.
|
46,800 | $1,062,828 |
All Filings in EXEL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,269,170 | 60,084 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,863,184 | 43,441 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,818,169 | 132,744 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $2,328,535 | 56,381 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,409,851 | 100,042 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,436 | 66 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,197 | 66 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||